Valneva Se Adr Stock Fundamentals
| VALN Stock | USD 6.79 0.24 3.41% |
Valneva SE ADR fundamentals help investors to digest information that contributes to Valneva SE's financial success or failures. It also enables traders to predict the movement of Valneva Stock. The fundamental analysis module provides a way to measure Valneva SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valneva SE stock.
Valneva |
Valneva SE ADR Company Return On Equity Analysis
Valneva SE's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Valneva SE Return On Equity | -0.0396 |
Most of Valneva SE's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Valneva SE ADR has a Return On Equity of -0.0396. This is 99.83% lower than that of the Biotechnology sector and 99.89% lower than that of the Health Care industry. The return on equity for all United States stocks is 87.23% lower than that of the firm.
Valneva SE ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE ADR is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valneva SE's earnings, one of the primary drivers of an investment's value.Valneva Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valneva SE's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics of similar companies.Valneva SE is currently under evaluation in return on equity category among its peers.
Valneva Fundamentals
| Return On Equity | -0.0396 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 611.02 M | ||||
| Shares Outstanding | 81.2 M | ||||
| Shares Owned By Institutions | 1.01 % | ||||
| Number Of Shares Shorted | 36.65 K | ||||
| Price To Book | 2.33 X | ||||
| Price To Sales | 3.55 X | ||||
| Revenue | 153.71 M | ||||
| Gross Profit | (5.08 M) | ||||
| EBITDA | (57.72 M) | ||||
| Net Income | (101.43 M) | ||||
| Cash And Equivalents | 336.22 M | ||||
| Cash Per Share | 5.74 X | ||||
| Total Debt | 208.82 M | ||||
| Debt To Equity | 1.43 % | ||||
| Current Ratio | 1.15 X | ||||
| Book Value Per Share | 1.55 X | ||||
| Cash Flow From Operations | (202.74 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Target Price | 15.39 | ||||
| Number Of Employees | 676 | ||||
| Beta | 1.11 | ||||
| Market Capitalization | 562.13 M | ||||
| Total Asset | 460.06 M | ||||
| Retained Earnings | (551.68 M) | ||||
| Working Capital | 103.96 M | ||||
| Net Asset | 460.06 M |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States.
When determining whether Valneva SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Valneva SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Valneva Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Valneva Se Adr Stock: Check out Valneva SE Piotroski F Score and Valneva SE Altman Z Score analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.